Notably, in this study, Gal-3 was the only biomarker independently associated with an increased risk of developing HF and death in patients with type 2 diabetes mellitus (HR 2.14 (95% CI: 1.18–3.91)). Here, LGALS3 is linked to type 2 diabetes mellitus.